MedPath

Clinical efficiency of a ready-to-use medium for human embryo culture supplemented with growth factors in patients with previous in vitro fertilization failures

Completed
Conditions
Intracytoplasmic sperm injection (ICSI) and embryo culture
Pregnancy and Childbirth
Registration Number
ISRCTN94726536
Lead Sponsor
Gynepro S.R.L.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
500
Inclusion Criteria

1. Female patients with at least one previous unsuccessful IVF attempt, in which a clinical pregnancy was not established (including biochemical pregnancies or miscarriages)
2. Aged between 25 and 45

Exclusion Criteria

1. Women older than 45 years old
2. Patients with male partners with testicular spermatozoa or severe oligoastenoteratozoospermia (total sperm number less than 1,000,000 and sperm motility less than 5%)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Implantation rate (defined as the number of implanted embryos per number of transferred embryos) is measured 30 days after embryo transfer.
Secondary Outcome Measures
NameTimeMethod
Pregnancy rate (defined as the number of pregnancies per number of transferred embryos) is measured using ultrasound of gestational chamber 30 days after embryo transfer.
© Copyright 2025. All Rights Reserved by MedPath